GB1150772A - Method of Preparing a Composition of Matter for the Treatment of Neoplasms - Google Patents

Method of Preparing a Composition of Matter for the Treatment of Neoplasms

Info

Publication number
GB1150772A
GB1150772A GB24724/66A GB2472466A GB1150772A GB 1150772 A GB1150772 A GB 1150772A GB 24724/66 A GB24724/66 A GB 24724/66A GB 2472466 A GB2472466 A GB 2472466A GB 1150772 A GB1150772 A GB 1150772A
Authority
GB
United Kingdom
Prior art keywords
centrifuging
neoplasms
treatment
preparing
matter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB24724/66A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmachim DSO
Original Assignee
Pharmachim DSO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachim DSO filed Critical Pharmachim DSO
Publication of GB1150772A publication Critical patent/GB1150772A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB24724/66A 1965-06-02 1966-06-02 Method of Preparing a Composition of Matter for the Treatment of Neoplasms Expired GB1150772A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG63865 1965-06-02

Publications (1)

Publication Number Publication Date
GB1150772A true GB1150772A (en) 1969-04-30

Family

ID=3897203

Family Applications (1)

Application Number Title Priority Date Filing Date
GB24724/66A Expired GB1150772A (en) 1965-06-02 1966-06-02 Method of Preparing a Composition of Matter for the Treatment of Neoplasms

Country Status (4)

Country Link
DE (1) DE1617426A1 (cg-RX-API-DMAC7.html)
FR (1) FR1592060A (cg-RX-API-DMAC7.html)
GB (1) GB1150772A (cg-RX-API-DMAC7.html)
NL (1) NL6607444A (cg-RX-API-DMAC7.html)

Also Published As

Publication number Publication date
NL6607444A (cg-RX-API-DMAC7.html) 1966-12-05
FR1592060A (cg-RX-API-DMAC7.html) 1970-05-11
DE1617426A1 (de) 1970-11-05

Similar Documents

Publication Publication Date Title
GB1385342A (en) Ligand determination of spin labelled compounds by receptor displacement
GB1303408A (cg-RX-API-DMAC7.html)
GB1204048A (en) Method for purifying native collagen
ES443353A1 (es) Un procedimiento para la obtencion de un producto proteinicoviscoso coagulable por calor.
NO931093L (no) Fremgangsmaate for fremstilling av rensede glykolipider ved membrana dskillelsesfremgangsmaaten
GB1375811A (cg-RX-API-DMAC7.html)
IE42369L (en) Peptide
GB1469908A (en) Preparation containing an enzyme for removal of anti-complement from gamma globulin
EP0158317A3 (en) Biologic and method of preparing same
GB1404225A (en) Extraction of physiologically active substrates from parathyroid
GB1300850A (en) Method of separating leucocytes from whole blood
IE39467B1 (en) Mercaptqmethylpyridines and their derivatives
GB1460163A (en) Purification of 6,7-methylene steroid lactones
IE32044B1 (en) Process for the manufacture of a tetanus-vaccine
Pope et al. The Properties of Crystalline Diphtheria Toxin-Protein: Observations on the Pepsin and Trypsin Stable Antigens
CA1034521A (en) PROCESS FOR THE PREPARATION OF 17-ACYL ESTERS OF 17.alpha.,21-DIHYDROXYSTEROIDS OF THE PREGNANE SERIES
ES8200228A1 (es) Metodo para producir preparados medicinales para el trata- miento de carcinomas
SU603389A1 (ru) Способ получени вещества коллагеназного действи
Mowrer My philosophy of psychotherapy.
ES434945A1 (es) Procedimiento para la obtencion de derivados del acido 2- cloroetanofosfonico.
Zwicker et al. Influence of Ge Additions to Cu-Sn Solid-Solutions on the Diffusion Process During Formation of Nb 3 Sn-Al 5 Phases and Their Superconducting Properties
Linggood Alum-Precipitated Diphtheria Toxoid
CA1010897A (en) Process for the preparation of 3-acetamido-5-amino-2,4,6-triiodobenzoic acid
SU596616A1 (ru) Способ получени кристаллической гуанил-рибонуклеазы
US2894875A (en) Method of producing the highly purified luteinizing gonadotropic factor

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee